What is Prolactinoma

A prolactinoma is a noncancerous (benign) tumor of the pituitary gland that causes the gland to produce too much of the hormone prolactin. This hormonal imbalance can disrupt reproductive health, bone density, and metabolic function, affecting individuals of all genders, though it is most frequently diagnosed in women of reproductive age.

What is a prolactinoma and how does it affect the body?

A prolactinoma originates in the anterior pituitary gland, a pea-sized structure at the base of the brain. When this tumor secretes excess prolactin, it suppresses the production of sex hormones like estrogen and testosterone. Because the pituitary gland acts as the body's "master gland," its dysfunction impacts multiple systems, including the reproductive system, skeletal health (leading to potential osteoporosis), and sometimes vision, if the tumor grows large enough to press on nearby optic nerves.

How are these tumors classified?

Clinicians classify a prolactinoma based on its physical size, which helps determine the treatment approach:

• Microprolactinomas: These are small tumors measuring less than 10 millimeters in diameter; they are more common in women.


• Macroprolactinomas: These are larger tumors measuring 10 millimeters or more; they are more frequently identified in men.

How common is a prolactinoma?

While often categorized as a rare condition, a prolactinoma is actually the most common type of pituitary tumor. Estimates suggest a prevalence of approximately 30 to 50 cases per 100,000 people. Although they can occur at any age, they are most often diagnosed in women between the ages of 20 and 50. Currently, 58 individuals within the DiseaseMaps.org community are managing their journey with a prolactinoma, highlighting the importance of shared experiences in navigating diagnosis and treatment.

What distinguishes a prolactinoma from other pituitary conditions?

Unlike other pituitary tumors that may require surgery as a first-line treatment, a prolactinoma is unique because it is highly responsive to medication. Dopamine agonists, such as cabergoline or bromocriptine, can effectively shrink the tumor and normalize hormone levels in the vast majority of patients, often making surgery unnecessary.

Next steps

• Consult an endocrinologist to discuss hormone testing and potential medication management.


• Monitor vision regularly if your doctor identifies a macroprolactinoma.


• Connect with the 58 members at DiseaseMaps.org to share support and lived experiences.


• Keep a detailed log of your symptoms to help your medical team track your progress.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Prolactinoma


• Orphanet: Prolactinoma


• The Pituitary Foundation: Understanding Prolactinomas


• PubMed/NCBI: Clinical Practice Guidelines for Pituitary Adenomas